Karbinal ER
NDC 23594-101, Carbinoxamine Maleate, suspension, extended release, from Aytu Therapeutics, LLC.
- Product NDC
- 23594-101
- Status
- Listed
- Labeler
- Aytu Therapeutics, LLC
- Dosage form
- SUSPENSION, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022556
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/23594-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARBINOXAMINE MALEATE4 mg/5mL
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 23594-101-01 | 23594010101 | 2 BOTTLE, PLASTIC in 1 CARTON (23594-101-01) / 30 mL in 1 BOTTLE, PLASTIC |
| 23594-101-05 | 23594010105 | 480 mL in 1 BOTTLE, PLASTIC (23594-101-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c40b3f4e-2d71-41a1-a1fc-f64f38724879NADAC price for package 23594010105
GET /v1/drugs/nadac/23594010105
Use it
Look up 23594-101 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/23594-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 23594-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.